Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onexton Gel in Acne Vulgaris
NCT01701024Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Oct 2012
- Primary completion
- May 2013
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clindamycin + benzoyl peroxide in acne vulgaris, sponsored by Valeant Pharmaceuticals. Started Oct 2012; status: completed.
02
Drugs
clindamycin + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01701024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01701024.